Valuation : AGP Limited

Market Cap 47.38B 171M 147M 138M 126M 237M 16.32B 238M 1.64B 639M 8.24B 641M 627M 27.32B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 47.38B 171M 147M 138M 126M 237M 16.32B 238M 1.64B 639M 8.24B 641M 627M 27.32B EV / Sales 2025
1.97x
EV / Sales 2026 * 1.49x
Free-Float
30.43%
Yield 2025
3.94%
Yield 2026 * 2.96%
1 day-0.28%
1 week-4.91%
Current month-11.38%
1 month-11.95%
3 months-10.99%
6 months-22.42%
Current year-16.71%
1 week 168.11
Extreme 168.11
179.45
1 month 168.11
Extreme 168.11
194.17
Current year 163
Extreme 163
258.67
1 year 163
Extreme 163
258.67
3 years 46
Extreme 46
258.67
5 years 46
Extreme 46
258.67
10 years 46
Extreme 46
258.67
Manager TitleAgeSince
Chief Executive Officer - 2023-12-31
Director of Finance/CFO - 2016-11-30
Chief Tech/Sci/R&D Officer - 2023-07-31
Director TitleAgeSince
Director/Board Member - 2018-06-06
Director/Board Member - 2023-12-31
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%-4.91%-11.52%+227.02% 171M
-0.13%-6.44%+60.34%+112.06% 1,047B
+0.85%-0.81%+51.29%+63.13% 646B
-1.03%-3.58%+21.43%+73.10% 451B
-1.46%-4.50%+37.80%+37.41% 355B
-0.72%-2.89%+22.32%+36.62% 291B
-1.19%-2.21%+1.53%+10.79% 252B
-1.05%-1.57%+50.30%+66.55% 234B
+0.08%-1.78%-17.64%-54.36% 203B
-2.14%-0.30%+28.95%+86.27% 181B
Average -0.71%-2.90%+24.48%+65.86% 365.94B
Weighted average by Cap. -0.46%-3.46%+38.17%+65.01%

Financials

2025 2026 *
Net sales 29.41B 106M 91.35M 85.65M 78.19M 147M 10.13B 148M 1.02B 396M 5.11B 398M 389M 16.96B 31.76B 114M 98.64M 92.49M 84.43M 159M 10.94B 160M 1.1B 428M 5.52B 430M 420M 18.31B
Net income - -
Net Debt - -
Logo AGP Limited
AGP Limited is a Pakistan-based pharmaceutical company. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of all kinds of pharmaceutical products. It owns a range of products catering to distinct therapeutic needs of the market. It offers a diverse portfolio of products in internal medicine, gynecology, pediatrics, nutraceutical, neuropsychiatry, cardiometabolic, hepatology, and orthopedic. Its products include Afdol, Nebcin, Exotan, Nergab, Febuxin, Zerifax, Protege, Maxna, Lucast, Urso, Kefzol, Algocin, Poze, Analar, Magnus MR, Novafol, Vita-NEM Plus, Colidrop, Daplazole, Lipomax, Rigix, and others. Its subsidiaries include OBS AGP (Private) Limited (OBS AGP) and OBS Pakistan (Private), which are in the business of trading pharmaceutical products.
Employees
2,143
Date Price Change Volume
26-08-28 PKR 169.20 -0.28% 201,429
26-08-27 PKR 169.68 -0.36% 270,005
26-08-25 PKR 170.29 -1.54% 955,140
26-08-24 PKR 172.95 -2.80% 833,596
26-08-21 PKR 177.94 -1.34% 510,220
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
169.20PKR
Average target price
246.40PKR
Spread / Average Target
+45.63%

Quarterly revenue - Rate of surprise